Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing (2023)

First Author: Achar J

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/13993003.00969-2023

PubMed Identifier: 37945035

Publication URI: http://europepmc.org/abstract/MED/37945035

Type: Journal Article/Review

Parent Publication: European Respiratory Journal

Issue: 5

ISSN: 0903-1936